期刊文献+

ELISA法检测血清CK-19在甲状腺乳头状癌鉴别诊断中的应用

下载PDF
导出
摘要 目的检测细胞角蛋白(cytokeratin,CK-19)在甲状腺乳头状癌(PTC)和结节性甲状腺肿患者血清中的表达,筛选甲状腺乳头状癌的辅助诊断指标。方法采用酶联免疫吸附试验(E1。1SA)法,检测结节性甲状腺肿30例,乳头状癌30例,正常人30例中CK-19的表达。结果(1)CK-19表达水平以甲状腺乳头状癌高[(27.48±6.91)ng/ml],结节性甲状腺肿居中[(9.75±3.58)ng/ml],正常人低[(6.54±2.32)ng/ml],三者差异有统计学意义(F=18.254,P〈0.05)。(2)以16ng/ml为界值,CK-19在结节性甲状腺肿与甲状腺乳头状癌患者血清中的表达率,两者差异有统计学意义(0=53.571,P〈0.05);此外,以10ng/ml为界值,CK-19在结节性甲状腺肿患者与正常人血清中的表达率,两者差异也有统计学意义(χ2=15.429,P〈0.05)。(3)CK-19表达水平在甲状腺乳头状癌伴淋巴结转移[(32.2±4.63)ng/ml]比未伴淋巴结转移者[(18.93±3.25)ng/ml]更高,两者差异有统计学意义(t=25.648,P〈0.05)。结论甲状腺乳头状癌患者外周血中CK-19表达率增高;CK-19对于甲状腺乳头状癌伴淋巴结转移的诊断具有一定的指导作用。 Objective To explore the value of detecting the expression of cytokeratin (eytokeratin, CK - 19) for thyroid papillary carcinoma(PTC) diagnosis. Methods By Enzyme -linked immunosorbent assay (ELISA) method, 30 cases of nodular goiter, 30 cases of papillary carcinoma, 30 cases of normal people were detected for CK - 19 expression. Results ( 1 ) CK - 19 expression level was high in papillary thyroid carcinoma(27.48 ± 6.91 ng/ml) , middle in nodular goiter (9. 75 ± 3.58ng/ml) , and low in normal(6. 54 ± 2.32 ng/ml). There is a significant difference of all. ( F = 18. 254, P 〈 0. 05 ) ; (2)To 16 ng / ml for the cutoff value, there was a significant difference (χ2 = 53.571,P 〈 0.05 ) of CK - 19 expression rate in nodular goiter and papillary thyroid carcinoma patients;Furthermore, when taking 10 ng / ml for the cutoff value, there was a significant difference too( χ2 = 15. 429, P 〈 0.05 ) of CK - 19 expression rate in nodular goiter patients and normal persons ; ( 3 ) CK - 19 expression level in papillary thyroid carcinoma with lymph node metastasis (32.2 ± 4. 63ng/ml) was higher than in those without lymph node metastasis (18.93 ± 3.25ng/ml). The difference was a significant ( t = 25. 648, P 〈 0. 05 ). Conclusions CK - 19 expression is increased in patients with papillary thyroid carcinoma; CK - 19 plays a guiding role in diagnosis of papillary thyroid carcinoma with lymph node metastasis.
作者 魏杨辉 黄耀
出处 《浙江临床医学》 2009年第7期694-696,共3页 Zhejiang Clinical Medical Journal
基金 2008年深圳市福田区公益性科研计划项目盘项FT-WS058
关键词 细胞角蛋白 甲状腺乳头状癌 血清 酶联免疫吸附试验法 Cytokeratin Papillary thyroid carcinoma Serum Enzyme -linked immunosorbent assay method
  • 相关文献

参考文献5

  • 1Cheung CC,Ezzat S,Freeman JL,et al.Immunohistochemieal diagnosis of papiUary thyroid carcinoma.Mod Pathol,2001,14:338 -342.
  • 2张静,丘钜世,陈金培,李雯,刘国荣.CK19、CK20在甲状腺乳头状癌诊断中的应用价值[J].临床与实验病理学杂志,2002,18(2):181-184. 被引量:24
  • 3陈晓东,周本成,赖日权,田野,冼江.细胞角蛋白表达在甲状腺乳头状癌诊断中的应用[J].诊断病理学杂志,2003,10(1):25-26. 被引量:20
  • 4Shin E,Chung WY,Yang Wl,et al.RET/PTC and CK19 expression in papillary thyroid carcinoma and its cl inicopathologic correlation.J Korean Med Sci,2005,20(1):98 - 104.
  • 5Sahoo S,Hoda SA,DeLellis RA,et al.Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma:a note of caution.Am J Clin Pathol,2001,116(5):696.

二级参考文献8

  • 1中山医科大学 同济医科大学.外科病理学,第2版[M].武汉:湖北科学技术出版社,1998.1299-304.
  • 2[1]Rosai J, Carcangin ML, Delellis RA. Atlas of tumor pathology: tumors of the thyroid gland. AFIP 3rd series, Fascicle 5,1992. 100
  • 3[2]Hedinger Chr, Williams ED, Sobin LH. Histological typing of thyroid tumor. 2nd ed, New York:Springer, 1998
  • 4[3]Baloch ZW, Abraham S, Roberts S et al. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol, 1999, 30:1166
  • 5[4]Nasser SM, Pitman MB, Pilch BZ et al. Fine-needle aspiration biopsy of papillary thyroid carcinoma: diagnostic utility of cytokeratin 19 immunostaining. Cancer, 2000,90:307
  • 6[5]Miettinen M, Kovatich AJ, Karkkainen P. Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications. Virchows Arch, 1997,431:407
  • 7廖松林.甲状腺常见疾病的病理诊断及鉴别诊断[J].临床与实验病理学杂志,2000,16(6):510-512. 被引量:6
  • 8刘勇,苏祖兰,龙捷,唐录英,何丹.367例甲状腺疾病临床病理诊断分析[J].临床与实验病理学杂志,2001,17(3):238-240. 被引量:24

共引文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部